MARCONI, GIOVANNI
MARCONI, GIOVANNI
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Ricercatori a tempo determinato
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment
2024 Bochicchio M.T.; Marconi G.; Baldazzi C.; Bandini L.; Ruggieri F.; Lucchesi A.; Agostinelli C.; Sabattini E.; Orsatti A.; Ferrari A.; Capirossi G.; Servili C.; Ghelli Luserna di Rora A.; Martinelli G.; Simonetti G.; Rosti G.
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease
2024 Kayser, Sabine; Sartor, Chiara; Giglio, Fabio; Bruno, Alessandro; Webster, Jonathan; Chiusolo, Patrizia; Saraceni, Francesco; Guerzoni, Selene; Pochintesta, Lara; Borlenghi, Erika; Marconi, Giovanni; Zacheo, Irene; Cerrano, Marco; Salutari, Prassede; Restuccia, Francesco; Abbenante, Mariachiara; Levis, Mark J.; Schlenk, Richard F.; Papayannidis, Cristina
Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy
2024 Rocchi, Serena; Zannetti, Beatrice Anna; Marconi, Giovanni; Lanza, Francesco
Novel approaches for hematopoietic stem cell mobilisation and collection need to be assessed for qualification and validation to accomplish the proper requirements of their intended purpose
2024 Lanza, Francesco; Marconi, Giovanni
Novel insights and therapeutic approaches in secondary AML
2024 Marconi, Giovanni; Rondoni, Michela; Zannetti, Beatrice Anna; Zacheo, Irene; Nappi, Davide; Mattei, Agnese; Rocchi, Serena; Lanza, Francesco
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
2023 Todisco, Elisabetta; Papayannidis, Cristina; Fracchiolla, Nicola; Petracci, Elisabetta; Zingaretti, Chiara; Vetro, Calogero; Martelli, Maria Paola; Zappasodi, Patrizia; Di Renzo, Nicola; Gallo, Susanna; Audisio, Ernesta; Griguolo, Davide; Cerchione, Claudio; Selleri, Carmine; Mattei, Daniele; Bernardi, Massimo; Fumagalli, Monica; Rizzuto, Giuliana; Facchini, Luca; Basilico, Claudia Maria; Manfra, Ilenia; Borlenghi, Erika; Cairoli, Roberto; Salutari, Prassede; Gottardi, Michele; Molteni, Alfredo; Martini, Vincenza; Lunghi, Monia; Fianchi, Luana; Cilloni, Daniela; Lanza, Francesco; Abruzzese, Elisabetta; Cascavilla, Nicola; Rivellini, Flavia; Ferrara, Felicetto; Maurillo, Luca; Nanni, Jacopo; Romano, Alessandra; Cardinali, Valeria; Gigli, Federica; Roncoroni, Elisa; Federico, Vincenzo; Marconi, Giovanni; Volpi, Roberta; Sciumè, Mariarita; Tarella, Corrado; Rossi, Giuseppe; Martinelli, Giovanni
Biological therapy in elderly patients with acute myeloid leukemia
2023 Ciotti G.; Marconi G.; Sperotto A.; Giannini M.B.; Gottardi M.; Martinelli G.
Editorial: Precision medicine for acute myeloid leukemia
2023 Marconi G.; Guolo F.; Nanni J.; Papayannidis C.
Hemophagocytic lymphohistiocytosis in gastric cancer: A rare syndrome for the oncologist. Case report and brief review
2023 Monti M.; Marconi G.; Ambrosini-Spaltro A.; Gallio C.; Ghini V.; Esposito L.; Antonini S.; Montanari D.; Frassineti G.L.
Personalizing precision medicine: Patients with AML perceptions about treatment decisions
2023 Grauman A.; Kontro M.; Haller K.; Nier S.; Aakko S.; Lang K.; Zingaretti C.; Meggiolaro E.; De Padova S.; Marconi G.; Martinelli G.; Heckman C.A.; Simonetti G.; Bullinger L.; Kihlbom U.
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study
2023 Marconi G.; Candoni A.; Di Nicola R.; Sartor C.; Parisi S.; Abbenante M.; Nanni J.; Cristiano G.; Zannoni L.; Lazzarotto D.; Giannini B.; Baldazzi C.; Bandini L.; Ottaviani E.; Testoni N.; Bezzi C.D.G.; Abd-alatif R.; Ciotti G.; Fanin R.; Martinelli G.; Paolini S.; Ricci P.; Cavo M.; Papayannidis C.; Curti A.
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients
2023 Ghetti, Martina; Vannini, Ivan; Bochicchio, Maria Teresa; Azzali, Irene; Ledda, Lorenzo; Marconi, Giovanni; Melloni, Mattia; Fabbri, Francesco; Rondoni, Michela; Chicchi, Roberta; Angeli, Davide; Ghelli Luserna di Rorà, Andrea; Giannini, Barbara; Zacheo, Irene; Biguzzi, Rino; Lanza, Francesco; Martinelli, Giovanni; Simonetti, Giorgia
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia
2022 Ragaini S.; Wagner S.; Marconi G.; Parisi S.; Sartor C.; Nanni J.; Cristiano G.; Talami A.; Olivi M.; Ocadlikova D.; Ciciarello M.; Corradi G.; Ottaviani E.; Papayannidis C.; Paolini S.; Vadakekolathu J.; Cavo M.; Rutella S.; Curti A.
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia
2022 Ravaioli F.; Marconi G.; Martinelli G.; Dajti E.; Sartor C.; Abbenante M.C.; Alemanni L.V.; Nanni J.; Rossini B.; Parisi S.; Colecchia L.; Cristiano G.; Marasco G.; Vestito A.; Paolini S.; Bonifazi F.; Curti A.; Festi D.; Cavo M.; Colecchia A.; Papayannidis C.
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x)
2022 Lin W.-Y.; Fordham S.E.; Hungate E.; Sunter N.J.; Elstob C.; Xu Y.; Park C.; Quante A.; Strauch K.; Gieger C.; Skol A.; Rahman T.; Sucheston-Campbell L.; Wang J.; Hahn T.; Clay-Gilmour A.I.; Jones G.L.; Marr H.J.; Jackson G.H.; Menne T.; Collin M.; Ivey A.; Hills R.K.; Burnett A.K.; Russell N.H.; Fitzgibbon J.; Larson R.A.; Le Beau M.M.; Stock W.; Heidenreich O.; Alharbi A.; Allsup D.J.; Houlston R.S.; Norden J.; Dickinson A.M.; Douglas E.; Lendrem C.; Daly A.K.; Palm L.; Piechocki K.; Jeffries S.; Bornhauser M.; Rollig C.; Altmann H.; Ruhnke L.; Kunadt D.; Wagenfuhr L.; Cordell H.J.; Darlay R.; Andersen M.K.; Fontana M.C.; Martinelli G.; Marconi G.; Sanz M.A.; Cervera J.; Gomez-Segui I.; Cluzeau T.; Moreilhon C.; Raynaud S.; Sill H.; Voso M.T.; Lo-Coco F.; Dombret H.; Cheok M.; Preudhomme C.; Gale R.E.; Linch D.; Gaal-Wesinger J.; Masszi A.; Nowak D.; Hofmann W.-K.; Gilkes A.; Porkka K.; Milosevic Feenstra J.D.; Kralovics R.; Grimwade D.; Meggendorfer M.; Haferlach T.; Krizsan S.; Bodor C.; Stolzel F.; Onel K.; Allan J.M.
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment
2022 Sartor C.; Arpinati M.; Chirumbolo G.; Dozza L.; Cristiano G.; Nanni J.; Marconi G.; Robustelli V.; Vigliotta I.; Parisi S.; Terragna C.; Testoni N.; Paolini S.; Martinelli G.; Curti A.; Cavo M.; Papayannidis C.
Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia
2022 Marconi, G; Piciocchi, A; Audisio, E; Priolo, G; Papayannidis, C; Martelli, M; Paoloni, F; Lemoli, RM; Bocchia, M; Lanza, F; Lico, A; Ciceri, F; Della Porta, MG; Frigeni, M; Giaccone, L; Beltrami, G; Borlenghi, E; Di Chio, MC; Selleri, C; Crea, E; Urbino, I; Sartor, C; Minotti, C; Guolo, F; La Sala, E; Nanni, J; Simonetti, G; Bochicchio, MT; Saglio, G; Venditti, A; Vignetti, M; Fazi, P; Martinelli, G
Hypomethylating Agent-Based Combination Therapies to Treat Post-Hematopoietic Stem Cell Transplant Relapse of Acute Myeloid Leukemia
2022 Ciotti G.; Marconi G.; Martinelli G.
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents
2022 Papayannidis C.; Nanni J.; Cristiano G.; Marconi G.; Sartor C.; Parisi S.; Zannoni L.; Saed R.; Ottaviani E.; Bandini L.; Testoni N.; Baldazzi C.; Solli V.; Ricci P.; Di Giovanni Bezzi C.; Abd-alatif R.; Stanzani M.; Paolini S.; Cavo M.; Curti A.
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
2022 Parisi S.; Ruggeri L.; Dan E.; Rizzi S.; Sinigaglia B.; Ocadlikova D.; Bontadini A.; Giudice V.; Urbani E.; Ciardelli S.; Sartor C.; Cristiano G.; Nanni J.; Zannoni L.; Chirumbolo G.; Arpinati M.; Lewis R.E.; Bonifazi F.; Marconi G.; Martinelli G.; Papayannidis C.; Paolini S.; Velardi A.; Cavo M.; Lemoli R.M.; Curti A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment | Bochicchio M.T.; Marconi G.; Baldazzi C.; Bandini L.; Ruggieri F.; Lucchesi A.; Agostinelli C.; S...abattini E.; Orsatti A.; Ferrari A.; Capirossi G.; Servili C.; Ghelli Luserna di Rora A.; Martinelli G.; Simonetti G.; Rosti G. | 2024-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-25-00118.pdf; ijms-25-00118-s001.zip |
| Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease | Kayser, Sabine; Sartor, Chiara; Giglio, Fabio; Bruno, Alessandro; Webster, Jonathan; Chiusolo, Pa...trizia; Saraceni, Francesco; Guerzoni, Selene; Pochintesta, Lara; Borlenghi, Erika; Marconi, Giovanni; Zacheo, Irene; Cerrano, Marco; Salutari, Prassede; Restuccia, Francesco; Abbenante, Mariachiara; Levis, Mark J.; Schlenk, Richard F.; Papayannidis, Cristina | 2024-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | 11375-Article Text-82869-2-10-20240423.pdf |
| Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy | Rocchi, Serena; Zannetti, Beatrice Anna; Marconi, Giovanni; Lanza, Francesco | 2024-01-01 | CELLS | - | 1.01 Articolo in rivista | 2024 MM immunotherapy and Auto-SCT_Lanza_Cells.pdf |
| Novel approaches for hematopoietic stem cell mobilisation and collection need to be assessed for qualification and validation to accomplish the proper requirements of their intended purpose | Lanza, Francesco; Marconi, Giovanni | 2024-01-01 | TRANSFUSION AND APHERESIS SCIENCE | - | 1.01 Articolo in rivista | - |
| Novel insights and therapeutic approaches in secondary AML | Marconi, Giovanni; Rondoni, Michela; Zannetti, Beatrice Anna; Zacheo, Irene; Nappi, Davide; Matte...i, Agnese; Rocchi, Serena; Lanza, Francesco | 2024-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | 2024 frontiers_Marconi_Novel insights...AML.pdf; Table_1.pdf |
| AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia | Todisco, Elisabetta; Papayannidis, Cristina; Fracchiolla, Nicola; Petracci, Elisabetta; Zingarett...i, Chiara; Vetro, Calogero; Martelli, Maria Paola; Zappasodi, Patrizia; Di Renzo, Nicola; Gallo, Susanna; Audisio, Ernesta; Griguolo, Davide; Cerchione, Claudio; Selleri, Carmine; Mattei, Daniele; Bernardi, Massimo; Fumagalli, Monica; Rizzuto, Giuliana; Facchini, Luca; Basilico, Claudia Maria; Manfra, Ilenia; Borlenghi, Erika; Cairoli, Roberto; Salutari, Prassede; Gottardi, Michele; Molteni, Alfredo; Martini, Vincenza; Lunghi, Monia; Fianchi, Luana; Cilloni, Daniela; Lanza, Francesco; Abruzzese, Elisabetta; Cascavilla, Nicola; Rivellini, Flavia; Ferrara, Felicetto; Maurillo, Luca; Nanni, Jacopo; Romano, Alessandra; Cardinali, Valeria; Gigli, Federica; Roncoroni, Elisa; Federico, Vincenzo; Marconi, Giovanni; Volpi, Roberta; Sciumè, Mariarita; Tarella, Corrado; Rossi, Giuseppe; Martinelli, Giovanni | 2023-01-01 | CANCER | - | 1.01 Articolo in rivista | Cancer - 2023 - Todisco - AVALON The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax.pdf |
| Biological therapy in elderly patients with acute myeloid leukemia | Ciotti G.; Marconi G.; Sperotto A.; Giannini M.B.; Gottardi M.; Martinelli G. | 2023-01-01 | EXPERT OPINION ON BIOLOGICAL THERAPY | - | 1.01 Articolo in rivista | BIOLOG~1.PDF |
| Editorial: Precision medicine for acute myeloid leukemia | Marconi G.; Guolo F.; Nanni J.; Papayannidis C. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Marconi_2023.pdf |
| Hemophagocytic lymphohistiocytosis in gastric cancer: A rare syndrome for the oncologist. Case report and brief review | Monti M.; Marconi G.; Ambrosini-Spaltro A.; Gallio C.; Ghini V.; Esposito L.; Antonini S.; Montan...ari D.; Frassineti G.L. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-13-1010561.pdf; DataSheet_1.pdf |
| Personalizing precision medicine: Patients with AML perceptions about treatment decisions | Grauman A.; Kontro M.; Haller K.; Nier S.; Aakko S.; Lang K.; Zingaretti C.; Meggiolaro E.; De Pa...dova S.; Marconi G.; Martinelli G.; Heckman C.A.; Simonetti G.; Bullinger L.; Kihlbom U. | 2023-01-01 | PATIENT EDUCATION AND COUNSELING | - | 1.01 Articolo in rivista | 1-s2.0-S073839912300263X-main (1).pdf; ScienceDirect_files_02May2024_08-19-35.149.zip |
| The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study | Marconi G.; Candoni A.; Di Nicola R.; Sartor C.; Parisi S.; Abbenante M.; Nanni J.; Cristiano G.;... Zannoni L.; Lazzarotto D.; Giannini B.; Baldazzi C.; Bandini L.; Ottaviani E.; Testoni N.; Bezzi C.D.G.; Abd-alatif R.; Ciotti G.; Fanin R.; Martinelli G.; Paolini S.; Ricci P.; Cavo M.; Papayannidis C.; Curti A. | 2023-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | CANCER~1.PDF; CAM4-12-11838-s001.docx |
| Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients | Ghetti, Martina; Vannini, Ivan; Bochicchio, Maria Teresa; Azzali, Irene; Ledda, Lorenzo; Marconi,... Giovanni; Melloni, Mattia; Fabbri, Francesco; Rondoni, Michela; Chicchi, Roberta; Angeli, Davide; Ghelli Luserna di Rorà, Andrea; Giannini, Barbara; Zacheo, Irene; Biguzzi, Rino; Lanza, Francesco; Martinelli, Giovanni; Simonetti, Giorgia | 2023-01-01 | BIOMÉDECINE & PHARMACOTHÉRAPIE | - | 1.01 Articolo in rivista | 2023 Biomedicine_Ghetti_Uncovering the expression of circPVT1.pdf; 1-s2.0-S0753332223010260-mmc1.docx |
| An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia | Ragaini S.; Wagner S.; Marconi G.; Parisi S.; Sartor C.; Nanni J.; Cristiano G.; Talami A.; Olivi... M.; Ocadlikova D.; Ciciarello M.; Corradi G.; Ottaviani E.; Papayannidis C.; Paolini S.; Vadakekolathu J.; Cavo M.; Rutella S.; Curti A. | 2022-01-01 | BLOOD ADVANCES | - | 1.01 Articolo in rivista | IDO1 score Ragaini Blood Advances.pdf; advancesADV2021004878-suppl1.pdf |
| Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia | Ravaioli F.; Marconi G.; Martinelli G.; Dajti E.; Sartor C.; Abbenante M.C.; Alemanni L.V.; Nanni... J.; Rossini B.; Parisi S.; Colecchia L.; Cristiano G.; Marasco G.; Vestito A.; Paolini S.; Bonifazi F.; Curti A.; Festi D.; Cavo M.; Colecchia A.; Papayannidis C. | 2022-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | Cancer Medicine - 2022 - Ravaioli - Assessment of liver stiffness measurement and ultrasound findings change during.pdf; CAM4-11-618-s005.zip |
| Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x) | Lin W.-Y.; Fordham S.E.; Hungate E.; Sunter N.J.; Elstob C.; Xu Y.; Park C.; Quante A.; Strauch K....; Gieger C.; Skol A.; Rahman T.; Sucheston-Campbell L.; Wang J.; Hahn T.; Clay-Gilmour A.I.; Jones G.L.; Marr H.J.; Jackson G.H.; Menne T.; Collin M.; Ivey A.; Hills R.K.; Burnett A.K.; Russell N.H.; Fitzgibbon J.; Larson R.A.; Le Beau M.M.; Stock W.; Heidenreich O.; Alharbi A.; Allsup D.J.; Houlston R.S.; Norden J.; Dickinson A.M.; Douglas E.; Lendrem C.; Daly A.K.; Palm L.; Piechocki K.; Jeffries S.; Bornhauser M.; Rollig C.; Altmann H.; Ruhnke L.; Kunadt D.; Wagenfuhr L.; Cordell H.J.; Darlay R.; Andersen M.K.; Fontana M.C.; Martinelli G.; Marconi G.; Sanz M.A.; Cervera J.; Gomez-Segui I.; Cluzeau T.; Moreilhon C.; Raynaud S.; Sill H.; Voso M.T.; Lo-Coco F.; Dombret H.; Cheok M.; Preudhomme C.; Gale R.E.; Linch D.; Gaal-Wesinger J.; Masszi A.; Nowak D.; Hofmann W.-K.; Gilkes A.; Porkka K.; Milosevic Feenstra J.D.; Kralovics R.; Grimwade D.; Meggendorfer M.; Haferlach T.; Krizsan S.; Bodor C.; Stolzel F.; Onel K.; Allan J.M. | 2022-01-01 | NATURE COMMUNICATIONS | - | 1.01 Articolo in rivista | s41467-021-27679-6.pdf |
| Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment | Sartor C.; Arpinati M.; Chirumbolo G.; Dozza L.; Cristiano G.; Nanni J.; Marconi G.; Robustelli V....; Vigliotta I.; Parisi S.; Terragna C.; Testoni N.; Paolini S.; Martinelli G.; Curti A.; Cavo M.; Papayannidis C. | 2022-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia | Marconi, G; Piciocchi, A; Audisio, E; Priolo, G; Papayannidis, C; Martelli, M; Paoloni, F; Lemoli..., RM; Bocchia, M; Lanza, F; Lico, A; Ciceri, F; Della Porta, MG; Frigeni, M; Giaccone, L; Beltrami, G; Borlenghi, E; Di Chio, MC; Selleri, C; Crea, E; Urbino, I; Sartor, C; Minotti, C; Guolo, F; La Sala, E; Nanni, J; Simonetti, G; Bochicchio, MT; Saglio, G; Venditti, A; Vignetti, M; Fazi, P; Martinelli, G | 2022-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| Hypomethylating Agent-Based Combination Therapies to Treat Post-Hematopoietic Stem Cell Transplant Relapse of Acute Myeloid Leukemia | Ciotti G.; Marconi G.; Martinelli G. | 2022-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Ciotti_2022.pdf |
| Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents | Papayannidis C.; Nanni J.; Cristiano G.; Marconi G.; Sartor C.; Parisi S.; Zannoni L.; Saed R.; O...ttaviani E.; Bandini L.; Testoni N.; Baldazzi C.; Solli V.; Ricci P.; Di Giovanni Bezzi C.; Abd-alatif R.; Stanzani M.; Paolini S.; Cavo M.; Curti A. | 2022-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | EJH-108-449.pdf; EJH-108-449-s001.docx |
| Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters | Parisi S.; Ruggeri L.; Dan E.; Rizzi S.; Sinigaglia B.; Ocadlikova D.; Bontadini A.; Giudice V.; ...Urbani E.; Ciardelli S.; Sartor C.; Cristiano G.; Nanni J.; Zannoni L.; Chirumbolo G.; Arpinati M.; Lewis R.E.; Bonifazi F.; Marconi G.; Martinelli G.; Papayannidis C.; Paolini S.; Velardi A.; Cavo M.; Lemoli R.M.; Curti A. | 2022-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | Parisi et al. 2021 - Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells - Alloreactive NK Cell Dose Still Matters.pdf |